← Back to Clinical Trials
Recruiting NCT03752775

NCT03752775 Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03752775
Status Recruiting
Phase —
Sponsor The Hong Kong Polytechnic University
Condition Upper Limb Rehabilitation
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2018-11-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Robot assisted upper limb rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2018-11-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A new clothing robotic arm was developed for multi-joint coordinated upper limb rehabilitation after stroke. Patients after stroke will be recruited to evaluate the rehabilitation effectiveness of the device assisted upper limb rehabilitation. Both patients with chronic stroke and subacute stroke will be investigated.

Eligibility Criteria

Inclusion Criteria: For the subacute groups: * Two weeks after the onset of stroke, however less than 0.5 year * Mini-Mental State Examination (MMSE)\>21 * Able to sit up for at least 1 hour * Fugl-Meyer Assessment (FMA) upper limb \<30 * Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3 * Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline) For the chronic device assisted group: * At least 0.5 year after the onset of stroke * Mini-Mental State Examination (MMSE)\>21 * Able to sit up for at least 1 hour * Fugl-Meyer Assessment (FMA) upper limb \<30 * Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3 * Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline) Exclusion Criteria: Subjects will be excluded if they do not meet the above inclusion criteria, or had the following conditions: * Currently pregnant * Dysphasia (language deficiency) * Post-stroke neglect * Pacemaker implantation, * Involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb * The overall medical condition not suitable for the training (e.g., severe cardiac problem, unstable blood pressure, etc.).

Contact & Investigator

Central Contact

Xiaoling Hu, PhD

✉ xiaoling.hu@polyu.edu.hk

📞 34003206

Frequently Asked Questions

Who can join the NCT03752775 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Upper Limb Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03752775 currently recruiting?

Yes, NCT03752775 is actively recruiting participants. Contact the research team at xiaoling.hu@polyu.edu.hk for enrollment information.

Where is the NCT03752775 trial being conducted?

This trial is being conducted at Hong Kong, China.

Who is sponsoring the NCT03752775 clinical trial?

NCT03752775 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology